Up a level |
Primrose, John N, Fox, Richard P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg et al (show 19 more authors)
(2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
LANCET ONCOLOGY, 20 (5).
pp. 663-673.
Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony et al (show 8 more authors)
(2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8).
pp. 565-575.
Toader, Alice-Maria ORCID: 0000-0002-3801-3486, Campbell, Marion K, Quint, Jennifer K, Robling, Michael, Sydes, Matthew R, Thorn, Joanna, Wright-Hughes, Alexandra, Yu, Ly-Mee, Abbott, Tom EF, Bond, Simon et al (show 25 more authors)
(2024)
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.
Trials, 25 (1).
p. 94.